HAEMONETICS CORP — Director's Dealing 2024

Jul 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2024-07-11

Reporting Person: Lingamneni Anila (EVP, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-11	Common Stock	S	2136	$90.00	Disposed	21410	Direct
2024-07-12	Common Stock	S	79	$90.00	Disposed	21331	Direct

Footnotes

F1: Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024).

F2: This number includes unvested restricted stock units previously reported.